{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-015884","form_type":"8-K","ticker":"DWTX","cik":"0001818844","company_name":"Dogwood Therapeutics, Inc.","filed_at":"2024-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.811181+00:00","generated_at":"2026-05-29T21:04:34.981052+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Dogwood Therapeutics receives Nasdaq delisting notice for low stockholders' equity","bullets":["Stockholders' equity fell below $2.5M minimum per Q3 2024 10-Q; delisting risk under Nasdaq Rule 5550(b)(1).","Company has until December 30, 2024 to submit a compliance plan; Nasdaq may grant up to 180-day extension.","Acquisition of Pharmagesic closed Oct 7, 2024, after the Q3 report, not reflected in equity calculation.","No immediate effect on listing; common stock (DWTX) continues trading on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-015884","json":"https://secwatch.observer/filing/0001558370-24-015884.json","markdown":"https://secwatch.observer/filing/0001558370-24-015884.md","text":"https://secwatch.observer/filing/0001558370-24-015884.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818844/000155837024015884/0001558370-24-015884-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818844/000155837024015884/dwtx-20241115x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T21:04:34.981052+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}